Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOTOX in Cervical Dystonia
NCT00564681Phase 2Completed
- Sponsor
- Allergan
- Start
- Dec 2007
- Primary completion
- Dec 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 16
01
Overview
A Phase 2 trial of onabotulinumtoxinA, botulinum toxin type A in cervical dystonia (CD), sponsored by Allergan. Started Dec 2007; status: completed.
02
Drugs
onabotulinumtoxinAbotulinum toxin type A
03
Conditions
cervical dystonia (CD)
Beyond the preview
Go deeper on NCT00564681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00564681.